Anti-BRAF/MEK Therapy
1 abstract
Abstract
Clinical outcomes with frontline immunotherapy (IO) in BRAF-mutant NSCLC.Org: Indiana University – Purdue University Indianapolis, Moffitt Cancer Center, Huntsman Cancer Institute, H. Lee Moffitt Cancer Center and Research Institute,